Literature DB >> 25503259

Oxidative stress in benign prostatic hyperplasia: a systematic review.

Paola Lucia Minciullo1, Antonino Inferrera, Michele Navarra, Gioacchino Calapai, Carlo Magno, Sebastiano Gangemi.   

Abstract

BACKGROUND: Several parameters including inflammatory mediators, hormones, dietary factors, inflammatory genes, and oxidative stress (OS) have been considered to play a role in the development of benign prostatic hyperplasia (BPH). Prostate tissue damage and OS may lead to compensatory cellular proliferation with resulting hyperplastic growth.
METHODS: We searched MEDLINE for articles in English published up to March 2014 using the key words 'oxidative stress', 'antioxidants' and 'benign prostatic hyperplasia'.
RESULTS: Prostatic inflammation can cause the generation of free radicals. The extent of oxidative damage can be exacerbated by a decreased efficiency of antioxidant defense mechanisms. The balance between OS and the antioxidant component also has a role in developing prostate disease. Several works show the role of oxidant products and of depletion of antioxidant substances in BPH patients. It is accepted that free radicals play a role in carcinogenesis and that BPH should be considered a premalignant condition which may evolve into prostate cancer. High OS parameters and low antioxidant activity are more prominent in prostate cancer patients compared with BPH and controls.
CONCLUSIONS: Further studies are needed to clarify the potential role of antioxidants in BPH also in view of preventing the progression to prostate cancer. 2014 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25503259     DOI: 10.1159/000366210

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  29 in total

1.  Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction.

Authors:  Samuel Thomas; Ling Hao; Kellen DeLaney; Dalton McLean; Laura Steinke; Paul C Marker; Chad M Vezina; Lingjun Li; William A Ricke
Journal:  J Proteome Res       Date:  2020-03-16       Impact factor: 4.466

2.  SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.

Authors:  Danyelle Winchester; Luisel Ricks-Santi; Tshela Mason; Muneer Abbas; Robert L Copeland; Desta Beyene; Emmanuel Y Jingwi; Georgia M Dunston; Yasmine M Kanaan
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

Review 3.  The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Authors:  Xun Fu; Huan Liu; Jiang Liu; Michael E DiSanto; Xinhua Zhang
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

4.  Oxidative stress promotes benign prostatic hyperplasia.

Authors:  Paz Vital; Patricia Castro; Michael Ittmann
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

5.  Potential of Moringa oleifera in the Treatment of Benign Prostate Hyperplasia: Role of Antioxidant Defence Systems.

Authors:  Ismail O Ishola; Kayode O Yemitan; Olasunmbo O Afolayan; Charles C Anunobi; Tobi E Durojaiye
Journal:  Med Princ Pract       Date:  2017-12-17       Impact factor: 1.927

Review 6.  Oxidative stress in prostate hyperplasia and carcinogenesis.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2016-09-08

Review 7.  Immunosenescence in aging: between immune cells depletion and cytokines up-regulation.

Authors:  Maria Teresa Ventura; Marco Casciaro; Sebastiano Gangemi; Rosalba Buquicchio
Journal:  Clin Mol Allergy       Date:  2017-12-14

Review 8.  Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?

Authors:  Chinedum Eleazu; Kate Eleazu; Winner Kalu
Journal:  Front Pharmacol       Date:  2017-04-28       Impact factor: 5.810

9.  Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells.

Authors:  ElShaddai Z White; Nakea M Pennant; Jada R Carter; Ohuod Hawsawi; Valerie Odero-Marah; Cimona V Hinton
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

10.  The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.

Authors:  Woong Jin Bae; Hyo Jung Park; Hye Cheong Koo; Do Ram Kim; U-Syn Ha; Kang Sup Kim; Su Jin Kim; Hyuk Jin Cho; Sung Hoo Hong; Ji Youl Lee; Sung Yeoun Hwang; Sae Woong Kim
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.